Teichmann Sarah A.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Aug 17, 2026
- Accession no.
- 0001610717-26-000359
- Filed
- Aug 17, 2026, 4:08 PM ET
- Trade date
- Aug 13-14, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $432.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Teichmann Sarah A.CIK 0002030916 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Class A Common Stock | SSaleDisposed | −5,278 | $57.29 | −$302,376.62 | 30,331 | Direct | |
| Aug 14, 2026 | Class A Common Stock | SSaleDisposed | −2,273 | $57.15 | −$129,901.95 | 28,058 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.